(Q33382342)
Statements
1 reference
Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results (English)
1 reference
Evanthia Galanis
1 reference
Marta Santisteban
1 reference
Bernd W Scheithauer
1 reference
Jan C Buckner
1 reference
Joel M Reid
1 reference
Wenting Wu
1 reference
Matthew M Ames
1 reference
Sara J Felten
1 reference
Daniel A Nikcevich
1 reference
Martin Wiesenfeld
1 reference
Kurt A Jaeckle
1 reference
North Central Cancer Treatment Group
1 reference
10 December 2008
1 reference
1 reference
92
1 reference
165-175
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference